High profile studies suggest that the benefits from improved utilisation can be enormous, and these studies include ones that attempt to put a value on the health gain that results from research [ 41, 42].
It suggests that while wood consumers always benefit from the utilisation of planted forests, this is not generally the case for wood producers.
Similarly to other integrated analyses, metabolic data analysis can likewise benefit from the utilisation of network information [ 26, 27].
As has been previously suggested, 23 future studies could benefit from the utilisation of genetically sensitive designs; in this study, we included pre-pregnancy weight in the genetic model and showed that there could be some intrauterine influence.
While there is increasing evidence of patient benefit from the utilisation of Clinical Practice Guidelines, clinician adherence and implementation remains poor and the failure to change clinician behaviour with the implementation of guidelines has been demonstrated in many areas of healthcare [ 1- 3].
The global public health field would also benefit from the utilisation of qualitative research and process evaluations to more deeply understand how interventions are working, what the unintended consequences are (if any) and to more deeply understand what the mechanisms are that account for change.
Further research is required to establish potential individual benefit from the utilisation of such networks, its suitability as a means of service provision feedback and the potential role for, and user acceptability of, mental health service providers operating within the space.
Thus, although the benefit to producers from utilisation of planted forests (second column in Table 8) was positive in all regions, totaling US$31 billion per year, or US$119 per hectare per year, it was generally not enough to compensate for the loss of profits on natural forests.
No medication is without risk, but the lessons learned from previous experience and new methods for post-market surveillance including updating of risks and benefits from new medications which evolve from utilisation in large numbers of 'real life' people need to be incorporated in a systematic and unbiased information resource [ 2, 4, 35].
Look for savings from utilisation management and inventory reductions.
